Stensen S, Krogh LL, Sparre-Ulrich AH, Dela F, et al. Acute concomitant GIP receptor antagonism during GLP-1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity. Diabetes Obes Metab 2022 May 1. doi: 10.1111/dom.14736.
PMID: 35491518